state-of-the-art treatment regimens for lr-mds
Published 3 years ago • 108 plays • Length 7:05Download video MP4
Download video MP3
Similar videos
-
2:04
state-of-the-art treatment for hr-mds
-
1:16
state of the art: mds
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
1:06
the current state of the art in hr-mds and the need to improve treatment approaches
-
11:33
treatment algorithm for low-risk mds
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
13:39
key highlights in mds: treating lower-risk & higher-risk disease, trial updates, and more
-
42:04
how to build your state-of-the-art for your clinical or performance evaluation?
-
3:10
the role of ngs in mds diagnosis
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
1:45
updates on the treatment of mds
-
2:43
novel therapies in the future of mds treatment
-
4:10
mds: state of the art in europe
-
2:38
how to treat difficult forms of mds
-
3:08
the treatment protocol for higher risk mds
-
3:37
progress in the categorization and treatment of lr-mds
-
1:22
key advances in mds management
-
3:04
expanding mds therapy options
-
1:20
the current standard of care for patients with lower-risk mds
-
3:38
a new set of treatment options for low-risk mds